While there are known associations of elevated FGF-23 and cardiovascular morbidities in chronic kidney diseases in both clinical and experimental studies, less is understood in an acute, hyperadrenergic setting [31,32]. This evidence concerns the gene FGF23 and chronic kidney disease.